title: Congenital melanocytic nevi: where are we now? Part II. Treatment options and approach to treatment.
abstract: Treatment of congenital melanocytic nevi (CMN) is generally undertaken for 2 reasons: (1) to reduce the chances of cutaneous malignant melanoma and (2) for cosmetic reasons. Over the past century, a large number of treatments for CMN have been described in the literature. These include excision, dermabrasion, curettage, chemical peels, radiation therapy, cryotherapy, electrosurgery, and lasers. Only low-level evidence supporting these approaches is available, and large randomized controlled trials have not been published. This article explores therapeutic controversies and makes recommendations based on the best available evidence.
authors.affiliation: Department of Dermatology, University of Connecticut Health Center, Farmington, Connecticut, USA.
authors.forename: Omar A
authors.initials: OA
authors.lastname: Ibrahimi
authors.forename: Ali
authors.initials: A
authors.lastname: Alikhan
authors.forename: Daniel B
authors.initials: DB
authors.lastname: Eisen
mesh_terms: D004502:Education, Medical, Continuing; D006801:Humans; D009508:Nevus, Pigmented / Q000151:congenital / Q000601:surgery* / Q000628:therapy*; D012878:Skin Neoplasms / Q000151:congenital / Q000601:surgery* / Q000628:therapy*